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ReviewRecognition of Chromosomal DNA
by PNAs
a complementary oligonucleotide that is likely to be a
high-affinity ligand. Once a sequence is chosen, efficient
protocols allow rapid synthesis and testing of com-
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University of Texas Southwestern Medical Center pounds for activity and make it possible to obtain hun-
dreds or thousands of oligonucleotides for large-scaleat Dallas
5323 Harry Hines Boulevard investigations of genome function. As potent inhibitory
oligonucleotides are identified and tested, oligonucleo-Dallas, Texas 75390
tides that contain mismatched bases can serve as con-
trol molecules to establish the mechanism and specific-
ity of the observed phenotype.The recognition of cellular nucleic acids by synthetic
A practical advantage for therapeutic development isoligonucleotides is a versatile strategy for regulating
that one oligonucleotide, Fomivirsen, is an approvedbiological processes. The vast majority of published
drug demonstrating that a member of this class of mole-studies have focused on antisense oligonucleotides
cules can advance through the regulatory process, whilethat target mRNA, but it is also possible to design
several others are in clinical trials [2, 3]. Clinical experi-antigene oligonucleotides that are complementary to
ence demonstrates that oligonucleotides can be effica-chromosomal DNA. Antigene oligomers could be used
cious, exhibit low toxicity, and can be synthesized onto inhibit the expression of any gene or analyze pro-
a large scale for systemic administration. Oligonucleo-moter structure and the mechanisms governing gene
tides are, therefore, a realistic option for therapy, andregulation. Other potential applications of antigene
their favorable properties will reduce the time neededoligomers include activation of expression of chosen
to translate a lead compound into a drug that can begenes or the introduction of mutations to correct ge-
tested in the clinic.netic disease. Peptide nucleic acid (PNA) is a nonionic
DNA/RNA mimic that possesses outstanding potential
for recognition of duplex DNA. Here we describe prop-
What Have We Learned from Targeting mRNA?erties of PNAs and the challenges for their develop-
The use of oligonucleotides to inhibit protein expressionment as robust antigene agents.
is not a new concept. Sequences within mRNA have
been the primary intracellular targets for oligonucleo-Introduction
tides, and the experience gained during 25 years ofDNA sequences can be viewed as an immense family
targeting mRNA is useful for planning experiments toof receptors and, like any receptors, are targets for the
target duplex DNA.design of synthetic ligands for use as experimental tools
Many studies have demonstrated that oligonucleo-and therapeutic leads. Potential applications that might
tides can act as potent and selective agents for inhibitingbenefit from recognition of duplex DNA include the inhi-
gene expression [2, 3]. Antisense oligomers, however,bition or activation of gene expression, the investigation
are notorious for forming unexpected interactions andof DNA structure and promoter function, and the intro-
producing phenotypes that are not related to binding toduction or correction of mutations at specific sites. How-
intended target sequences [4] (Figures 2A and 2B), andever, before these applications can become routine, it
achieving useful results demands that experiments bewill be necessary to synthesize agents that efficiently
well planned and well controlled. One cause for arti-and specifically recognize chromosomal DNA.
factual phenotypes is binding of oligonucleotides toIn this review we describe one synthetic approach
RNA or DNA sequences that are similar to the intendedtoward meeting this challenge, the DNA/RNA mimic
target. Artifactual phenotypes may result from oligomerspeptide nucleic acid (PNA) [1] (Figure 1). We focus on
binding to proteins, and oligomers that form G quartetPNA because it has an unparalleled ability to recognize
and other secondary structures are especially suscepti-complementary sequences by strand invasion and may
ble to such interactions [5]. Indeed, it is not clear that theprovide a general solution to the problem of gaining
molecules currently being tested in the clinic functionaccess to double-stranded DNA (dsDNA). We will briefly
through an antisense mechanism. There is every reasonreview relevant lessons from antisense oligonucleotides
to believe that agents targeting duplex DNA will alsothat target mRNA and then describe the development
produce misleading results if experiments are not wellof PNAs as antigene agents.
controlled. It is essential, therefore, that oligomers con-
taining mismatched bases be used and that results be
Advantages of Oligonucleotides examined critically [6].
for Chemical Genetics Another lesson from the study of antisense oligonucle-
Nucleic acids possess significant advantages as chemi- otides is that successful use of oligonucleotides in cul-
cal genetic tools for manipulating cellular processes [2, tured cells is governed by a window of efficacy bounded
3]. The most obvious advantage is that examination of by a minimum dose needed to produce a phenotype
a target sequence immediately suggests the design of and a maximum dose that marks the beginning of unac-
ceptable toxicity or confounding nonspecific effects
(Figure 2B). The size of the window will vary depending*Correspondence: david.corey@utsouthwestern.edu
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Recognition of dsDNA: Triplex Forming
Oligonucleotides (TFOs)
Oligonucleotides can recognize duplex DNA by binding
in the major groove through Hoogsteen base pairing
and triple helix formation (Figure 3A) [9, 10]. Hoogsteen
pairing involves bonding of protonated cytosine with AT
Watson-Crick base pairs and thymine with GC pairs,
and efficient recognition of duplex targets can be
achieved by forming a parallel complex between poly-
pyrimidine oligonucleotides and a polypyrimidine-
polypurine sequence within dsDNA. Some progress has
been made toward increasing the number of target se-
quences by developing strategies that allow recognition
by oligonucleotides containing a few purine bases. The
specificity of triplex recognition is stringent, with a single
mismatched base reducing melting temperature (Tm) val-
ues by as much as 15C [11, 12].
The great advantage of triple helix formation is that
the polypyrimidine strand binds within the major groove
of the target duplex. Therefore the target sequence does
not need to become single stranded, removing an ener-
getic barrier to hybridization. However, in spite of this
Figure 1. Structures of DNA, PNA, and LNA
strength, triplex formation has not yet achieved its full
The structures of DNA, PNA, and LNA are listed on the left. Charac-
potential as a tool for recognition of chromosomal DNAteristics relevant to strand invasion are noted on the right.
inside cells. One reason is that target sequences are
still largely restricted to polypurine-polypyrimidine du-
plexes, and these sequences may not always be near
on cellular target, chemical properties of the oligomer, sites that are critical to expression of a target gene.
purity, method of delivery, and cell type. The challenge Another deficiency is that binding by TFOs is relatively
in all experiments is to work within this window and to weak, especially at neutral or basic pH, and may not be
increase its size through chemical innovation and wise adequate for routine recognition of cellular targets.
choice of target. For example, the inhibition of gene Recognition of dsDNA: Strand Invasion
expression by duplex RNA (siRNA) [7] has become a In classic early studies, Radding and coworkers showed
popular technique because the window for achieving that single-stranded DNA can bind to supercoiled DNA
useful results is large. We expect that the window for by hybridizing to one strand of the duplex through Wat-
agents that target duplex DNA will need to be equally son-Crick base pairing while displacing the other (Figure
permissive before applications spread beyond a handful 3B) [13], a phenomenon known as strand invasion. This
of specialist laboratories. exciting result suggested that duplex DNA could be tar-
geted regardless of sequence, but progress toward de-
veloping strand invasion as a strategy for the recognition
Chromosomal DNA as a Target of dsDNA by synthetic oligomers has been slow. The
for Oligonucleotides primary obstacle is that strand invasion must overcome
Differences between Chromosomal DNA preexisting base pairing of the duplex to initiate and
and mRNA maintain recognition. Compounding this difficulty, rela-
While it is important to appreciate lessons learned from tively low concentrations of cations stabilize duplex DNA
work with antisense oligomers, there are fundamental and hinder strand invasion.
differences between mRNA and duplex DNA that will DNA oligonucleotides can invade supercoiled DNA at
influence plans for targeting chromosomes. One differ- 37C [14, 15]. However, this invasion is slow, inefficient,
ence is that mRNA is partially single-stranded, while and largely restricted to sequences that are partially
chromosomal DNA is almost entirely double-stranded single stranded because they are AT-rich or form cruci-
and is packaged with protein into chromatin. Therefore, forms. Rate constants for strand invasion of supercoiled
accessibility to target sequences within DNA will be plasmid DNA by DNA oligonucleotides can be enhanced
limited, and initiating hybridization will be more chal- up to 48,000-fold by conjugation to a cationic peptide
lenging. Another difference is that most effective anti- or protein that acts to increase favorable electrostatic
sense agents induce the cleavage of mRNA (either by interactions with the duplex [14]. However, only a few
RNase H in the case of RNA-DNA hybrids [8] or by the sequences within supercoiled DNA could be recognized
RISC complex for duplex RNA [7]), while agents that efficiently by the modified oligonucleotide, and relaxed
target duplex DNA will usually be required to leave the DNA remained inaccessible [15].
DNA intact. Finally, the target sequence of an antisense
oligonucleotide is carried on hundreds or thousands PNAs: Powerful Tools for Recognition of dsDNA
of mRNAs, while the target sequence for an antigene The Need for a New Approach
oligonucleotide is usually present only once or twice in Limitations on triplex formation or strand invasion are
not major impediments for most work in cell-free sys-the genome.
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Figure 2. Challenges to the Observation of
Accurate Phenotypes
(A) Observed phenotypes might result from
specific or nonspecific interactions between
antigene oligonucleotides and cellular com-
ponents. Specific effects would result from
binding to the intended target sequence on a
chromosome. Misleading phenotypes might
arise from binding to cellular proteins or to
non-target mRNA and DNA sequences. Mis-
leading phenotypes, especially reduced pro-
liferation, can also result from contaminants
introduced during cellular delivery of oligonu-
cleotides.
(B) The window for successfully using oligo-
nucleotides and PNAs to control cellular pro-
cesses. Concentrations that are too high will
produce toxicity and unintended phenotypes.
Concentrations that are too low will not affect
expression of the target gene. Chemical
modifications and cellular delivery strategies
that increase the range of effective doses
will increase the likelihood that PNAs and
other chemically modified oligomers will be
widely useful for research and therapeutic de-
velopment.
tems, because experimental conditions can be opti-
mized to promote recognition. For example, pH can be
lowered to favor triplex formation, or DNA can be dena-
tured by high pH or heat to facilitate strand invasion.
Inside cells, however, it will be much more difficult to
manipulate these variables to affect the environment of
chromosomal target sequences. DNA oligonucleotides,
therefore, appear to have limited potential for both triple
helix formation and strand invasion inside cells. Chemi-
cal modifications to DNA or to compounds that mimic
DNA, however, may provide the improvement in recogni-
tion necessary to make routine binding to cellular targets
a practical goal.
Properties of PNAs
PNA is an RNA/DNA mimic in which the phosphate de-Figure 3. Recognition of Duplex DNA by Oligonucleotides
oxyribose backbone is replaced by a neutral amide(A) Triplex helix formation at a polypurine-polypyrimidine sequence.
backbone composed of N-(2-aminoethyl) glycine link-(B) Strand invasion at a sequence containing a mixture of A, C, G,
and T. age (Figure 1) [1]. Base pairing by PNAs is not affected
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ble of forming cruciforms and within AT-rich regions thatTable 1. Advice for Successful Use of PNAs
are relatively unstable.
Realize that almost any PNA or PNA-peptide can be synthesized A striking example of strand invasion by mixed se-
Appreciate that the physical properties of PNA are more quence PNAs is the ability of a PNA that contains a
similar to peptides than to DNA or RNA
fourteen base hairpin stem structure to bind to an in-As with peptides, repeat the coupling of linkages with higher
verted repeat within supercoiled DNA (Figure 4G) [16,failure rates during synthesis
27]. One might have expected that this hairpin wouldMake stock PNA solutions at low pH (5) to increase solubility
Heat PNAs solutions prior to use to reverse aggregation that be stable and that hybridization would be slow, but in
occurs during storage fact the association rate constant (ka) for hybridization
Add charged residues if additional solubility is desired by strand invasion to a cruciform site with supercoiled
Be prepared to obtain several PNAs for systematic and well-
DNA is estimated at 500,000 M1, similar to the rate forcontrolled experiments
hybridization of two unstructured single stranded DNACarefully desalt PNAs prior to adding them to cells
oligonucleotides. Strand invasion can also occur at sitesAs with classical antisense oligonucleotides, demand robust
and reproducible results lacking the potential to form non-B-type structure, albeit
with lower efficiency, and can be promoted by attach-
ment of cationic peptides [39]. Mixed sequence PNAs
can also hybridize to linear duplex DNA, but nonphysio-by intrastrand electrostatic repulsion and occurs with
logical hybridization temperatures, low pH, low ionichigh affinity and enhanced rates of association [16] with
strength, or organic solvents will usually be necessary.strict sequence specificity [17–19]. Other properties of
Another related approach to duplex recognition usesPNAs that encourage their use inside cells include resis-
pseudocomplementary PNAs (pcPNAs) [40] (Figure 4B).tance to degradation by nucleases or proteases [20] and
pcPNAs contain modified bases such as diaminopurinelow affinity for proteins [21]. Unlike DNA oligonucleo-
(D) and 2-thiouracil (sU) designed to minimize the poten-tides that form RNA-DNA hybrids that can be cleaved
tial for base pairing between PNA strands but to permitby RNase H, RNA-PNA hybrids are not cleaved [22],
Watson-Crick recognition of A, C, G, and T of bothreducing the likelihood of nonsequence-specific pheno-
strands of the DNA target. These pcPNAs are able totypes.
hybridize to form a double-displacement loop and arePNAs are synthesized using methods adapted from
able to invade relaxed DNA. PcPNAs have been demon-peptide synthesis, and almost any PNA, PNA-peptide,
strated to block binding of proteins to DNA [41, 42], aor PNA-small molecule conjugate can be obtained, in-
property likely to be important for their eventual use ascluding sequences that are long (40–50 couplings), pu-
antigene agents.rine rich, or hairpins [23]. The ease with which PNAs can
Perhaps the simplest approach to strand invasion de-be derivatized facilitates combining the DNA binding
pends on the remarkable ability of PNAs to spontane-properties of PNA with functional peptides and small
ously invade polypyrimidine sites within relaxed DNAmolecules to enhance hybridization or uptake by cells,
[43–46]. Strand invasion of relaxed DNA by PNAs canor to improve pharmacokinetic properties. PNAs are not
occur at polypurine-polypyrimidine sites through forma-as soluble as DNA or RNA, but their use is straight-
tion of a four-stranded complex in which one PNA strand
forward when simple precautions are taken [23, 24] (Ta-
binds by Hoogstein base pairing while the other binds
ble 1).
by Watson-Crick base pairing (Figure 4C). Mechanistic
Strand Invasion by PNAs studies suggest that association of the bisPNA with its
PNAs have a remarkable ability to invade dsDNA that DNA target is initiated by Hoogstein pairing between
sets PNAs apart from other chemically modified nucleic the DNA and one of the PNA strands, with the second
acids and nucleic acid mimics. Strand invasion by PNAs PNA strand then invading the duplex [43]. The efficiency
is more efficient than strand invasion by modified DNA of strand invasion can be improved by tethering the two
or RNA because the uncharged PNA backbone is not PNA strands to form a bisPNA, because attaching the
repelled by the negatively charged phosphodiester strands reduces the entropic penalty paid upon binding
backbone of the duplex. This absence of repulsion in- [44] (Figure 4D). Stand invasion by bisPNAs can be fur-
creases the on rate for hybridization and decreases the ther improved by attaching positively charged amino
off rate. Applications for strand invasion by PNAs have acids [44, 45] (Figures 4E and 4H) or DNA intercalators
included purification of genomic DNA [25, 26], cleavage [46]. Polypyrimidine PNAs that contain extensions with
of DNA [27, 28], creation of artificial primosomes [16, mixtures of purines and pyrimidines (termed tail clamp
29], inhibition of transcription [30, 31], activation of tran- PNAs) also hybridize to duplex DNA (Figure 4F) [72, 73],
scription [32, 33], site-directed mutagenesis [34], non- extending the range of accessible target sites.
covalent labeling of plasmids with fluorophores [35], Most of the reports of strand invasion noted above
recruitment of transcription factors to an artificial pro- have used low ionic strength to promote unwinding of
moter [36], and recognition of duplex DNA by molecular the target duplex and initiation of hybridization by PNAs.
beacons [37]. Since higher ionic strength conditions will be encoun-
Strand invasion of both linear and supercoiled duplex tered inside cells, it is not clear that existing PNA designs
DNA by PNAs is spontaneous, and there are several will be able to accomplish strand invasion with the effi-
strategies for designing PNAs to recognize duplex DNA. ciencies observed in cell-free systems. One solution to
PNAs containing mixtures of A, C, T, and G can hybridize this problem is to attach positively charged amino acids
to supercoiled DNA [16, 38, 39] (Figure 4A). Hybridization to the PNAs, a simple alteration that allows PNAs to
is promoted by the negative torsional stress of su- invade duplex DNA at physiologic concentrations of
magnesium, sodium, and potassium [38, 44, 45]percoiling and is most efficient at inverted repeats capa-
Review
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Figure 4. Strategies for Strand Invasion by
PNAs and Examples of the Efficient Strand
Invasion by PNAs and PNA-Peptide Conju-
gates
(A) Strand invasion by a mixed sequence
PNA.
(B) Strand invasion by two psuedocomple-
mentary PNAs to form a double D loop. X,
2-thiouracil; D, diaminopurine.
(C) Strand invasion of a polypyrimidine-poly-
purine site by two polypyrimidine PNAs to
form a four-stranded complex in which one
strand binds by Hoogstein base-pairing and
one strand binds by Watson-Crick base
pairing.
(D) Strand invasion by a bis-polypyrimidine
bisPNA in which the two PNA strands are
attached by a flexible linker.
(E) Strand invasion by a bisPNA-peptide con-
jugate containing cationic amino acids.
(F) Strand invasion by a tail clamp PNA con-
taining a mixed base extension from a poly-
pyrimidine core sequence.
(G) PNA hybridization to structured DNA se-
quences. A hairpin PNA complementary to
an inverted repeat (target sequence shaded)
within supercoiled duplex DNA overcomes in-
tramolecular base pairing and hybridizes with
a rate association constant of 500,000 M1
s1 [16, 27].
(H) Positive charge attached to the N terminus
of PNAs dramatically increases the rate of
strand invasion of linear nonsupercoiled DNA
[43]. Indicated peptides were attached to the
N terminus of the bisPNA shown. ka values
are relative to the bisPNA with one lysine on
the N terminus (ka  340 M1 s1). The highest
ka value was achieved with attached peptide
D-(AAKK)4, 90,000 M1 s1. D denotes D
amino acids.
While this review focuses on PNAs, other modified The hybridized PNA is carried along as cargo and then
released once inside the cell by melting of the complex.bases and nucleotides can also be incorporated into
oligomers with dramatically improved recognition prop- PNAs delivered into cells by this method have been
shown to inhibit telomere synthesis by human telom-erties. For example, introduction of a single locked nu-
cleic acid (LNA) base (Figure 1) can raise the melting erase [49] and to bind mRNA and inhibit expression of
luciferase [50], human caveolin [75], and human proges-temperature of an oligonucleotide by up to 10C,
allowing extremely avid binding to be achieved [47]. terone receptor (B.A.J., unpublished data). The inhibition
of mRNA by PNAs delivery by this strategy is as efficientComparison of strand invasion by PNAs with that of
other chemically modified oligomers will be an ongoing and as prolonged as inhibition by analogous siRNAs
[75]. Advantages of this method are that the PNA doespriority.
Cellular Uptake of PNAs not require chemical modification and standard trans-
fection protocols can be used. A disadvantage is thatCellular uptake is a major barrier to successful use of
oligonucleotides inside cells. Fortunately, several meth- use of lipid adds an extra experimental step. It is likely
that this simple method has not become more widelyods have been developed to promote entry of PNAs into
cells. used because its successful use requires that a labora-
tory be familiar with the chemical properties of PNAsOne strategy for achieving cellular uptake involves
annealing PNAs to negatively charged DNA oligonucleo- and possess expertise performing transfections of
mammalian cell culture.tides and then complexing the heteroduplex with cat-
ionic lipid [48]. In this variation of standard protocols PNAs have also been introduced into cells by electro-
poration to inhibit telomerase activity [51] and alterfor delivering RNA or DNA into cells, the lipid binds to
the DNA, allowing it to pass through the cell membrane. mRNA splicing [52]. This approach does not require
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modification of the PNA, but does require specialized target sequence for PNAs (Figures 5A–5C). Transcription
factor binding sites represent one class of target, be-equipment and expertise. Microinjection of oocytes has
cause hybridization should disrupt assembly or regula-become a widely used method for delivery of morpholino
tion of the transcriptional apparatus. To date, no dataoligonucleotides in studies of inhibition of specific genes
is available regarding how near PNAs must be to a targeton early development [53], and it is likely that PNAs can
site to be able to disrupt protein binding, and this will bebe delivered using a similar method. Use of oocytes for
an important variable to investigate. The transcriptionalchemical genetic analysis by antigene PNAs would be an
start site is another target, because the open compleximportant breakthrough. Cell volume does not increase
formed by RNA polymerase is likely to offer a single-during early development, allowing PNAs to be active
stranded region that Sigman and coworkers have dem-throughout many cell divisions and facilitating the study
onstrated to be susceptible to binding by syntheticof embryonic phenotypes that often also have relevance
oligomers [59]. It may also be possible for oligomers toto adult animals.
bind downstream of the start site and act as a transcrip-Spontaneous uptake of PNAs by cells can be achieved
tional roadblocks. It is not known, however, whetherby attachment of peptide sequences that promote trans-
binding is strong enough to stop the forward progresslocation across cell membranes [54, 55]. One advantage
of the transcription machinery in mammalian cells.of this approach is that lipid is not necessary, making
If a polypyrimidine-polypurine sequence is presentthe procedure more straightforward. Another advantage
within a promoter, it may be possible to disrupt tran-of this approach is that the peptide might also be used
scription with a bisPNA through strand invasion andto promote nuclear uptake. Disadvantages are that addi-
formation of a four-stranded complex. Alternatively,tional synthetic steps are needed to add the peptide to
PNAs can be targeted to sequences that form non-B-the PNA and relatively high concentrations of PNA are
type structures. The advantage of targeting non-B-typerequired. In animals, uptake of PNAs tagged with four
structures is that they often contain some single-lysine residues has been shown to occur in a variety of
stranded bases, providing a convenient place for thetissues in mice and alter splicing [56]. Development of
initiation of strand invasion. PNAs bind within the hairpinconjugates between PNAs and peptides or peptoids
stems of DNA cruciforms [16, 60] and within guanine-may ultimately be the method needed to achieve break-
rich DNA that forms G quadruplex structure [61, 62].through results in vivo. PNAs with minimal modifica-
As an example of the type of non-B-type structuretion can enter cultured cells and alter splicing, but only
that PNAs might target, Hurley and colleagues havewhen high concentrations are present in the growth me-
recently raised the exciting hypothesis that G quad-dium [57].
ruplexes form within chromosomal DNA and act as im-The success of antigene PNAs requires that they enter
portant regulatory sites for gene expression (Figure 5B)the nucleus. To date, it is not clear whether nuclear
[63]. Binding of a PNA to the G-rich strand might preventuptake will present a significant obstacle for PNAs in-
the quadruplex from forming and disrupt its ability totended to bind chromosomal DNA. Fluorophore-labeled
regulate expression. Conversely, binding of a PNA toPNAs do not appear to accumulate in the nucleus (K.K.
the C-rich strand might promote quadruplex structureand C. Nulf, unpublished data), but failure to observe
and increase regulation.uptake by microscopy does not necessarily indicate that
The gene for the human progesterone receptor [64]insufficient amounts are entering for regulation of gene
offers an example of a gene with several promising tar-expression. Indeed, the experiments that report alter-
get sites (Figure 5C). These include several relatively
ation of splicing provide a clear indication that some
long polypyrimidine sequences that might be ideal
PNA can enter the nucleus [53, 56, 57]. If nuclear uptake
sights for polypyrimidine bisPNAs and a long inverted
is problematic for some applications, PNAs can be mod-
repeat that might form a cruciform capable of readily
ified with peptides containing nuclear localization se- binding to mixed-base PNAs. The human progesterone
quences (NLS), and PNA-NLS conjugates have shown receptor has two distinct promoters that regulate the
improved localization [58]. transcription of two different isoforms. Targeting these
promoters separately would offer an approach for iso-
form-specific inhibition of gene expression. Thus, there
Recognition of Chromosomal DNA are numerous plausible target sites within the gene that
Choosing Targets for Chromosomal Recognition are both functionally important and have sequences
Strand invasion by PNAs is remarkably efficient in cell- that are susceptible to strand invasion.
free systems, but success is less certain in complex Inhibition of Transcription
cellular environments. To improve the likelihood that Published data indicate that PNAs can efficiently block
experiments inside cells will produce useful data, it is transcription in cell-free systems [30, 31, 65]. There have
necessary to carefully consider the choice of target also been reports of antigene PNAs being used to inhibit
genes. There should be a rapid and sensitive assay for gene expression in cultured cells and in animals [66, 67].
its expression so that experiments capable of detecting While these results are promising, the data for antigene
modest levels of inhibition can be done quickly. It is effects inside cells are not as clear or well controlled as
also essential that the gene sequence and promoter the work in cell-free systems, and more work will be
sequence be well characterized to allow the identifica- necessary to establish the potential of antigene PNAs
tion of unambiguous sequences near sites important for for the regulation of cellular processes. Future studies
transcription. will need to be systematic and include ample controls
to demonstrate that observed effects are due to PNAsIt is possible to envision several different types of
Review
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Figure 5. Antigene PNAs, General Scheme, and Specific Promising Targets
(A) Types of potential targets for antigene PNAs.
(B) Targeting PNAs to G quartet secondary structure. PNAs can disrupt G quartet structure by binding to G-rich sequences. PNAs may be
able to stabilize G quartet structure by binding to the complementary strand. We depict G quartet formation activating transcription, but G
quartet formation may also repress transcription [63].
(C) Targets for antigene PNAs in the human progesterone receptor [64]. Targets include multiple polypurine-polypyrimidine sequences, multiple
transcription start sites, two isoforms, and a partial inverted repeat/cruciform.
binding to their intended targets. Once an unambiguous ies have reported that simply hybridizing PNAs within
the promoter region can cause a modest increase inantigene effect is established, an important goal for
these studies will be to establish predictive rules govern- gene expression [32, 33]. The mechanism of this upregu-
lation is not clear but may involve recognition of theing selection of target sequences (i.e., polypurine-poly-
pyrimidine, non-B-type, open complex, etc.). displaced strand by proteins involved in transcription.
Another strategy for accomplishing this end is to at-Activation of Transcription
Activation of gene transcription is another potential ap- tach a PNA to a peptide or small molecule capable of
binding to a transcription factor. The resulting conjugateplication for duplex recognition by PNAs (Figure 6). Stud-
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troduction of mutations. PNAs have been shown to facili-
tate the action of the recombination protein RecA [71],
and this ability to act in concert with recombination
enzymes may permit useful mutagenesis frequencies to
be achieved.
Where Do We Go from Here?
Ten years of work with PNAs has demonstrated that
they can readily invade linear and supercoiled DNA and
Figure 6. PNA Conjugates as Artificial Activators of Transcription
can function to control gene expression or introduce
A PNA that binds within a promoter region and an attached transcrip-
mutations. However, reports of effects inside cells aretion activation domain triggers transcription by recruiting RNA poly-
relatively few, and it is clear that the field has a longmerase [36].
way to go before antigene PNAs become widely ac-
cepted tools. The challenge confronting workers in the
would be a synthetic transcription activator capable of field is to build upon previous work and develop repro-
recruiting the transcription machinery. Initial work from ducible protocols that can be successfully employed by
Kodadek and coworkers has shown that a conjugate laboratories that have never worked with PNAs before.
consisting of a PNA attached to a peptide selected by Specific experimental goals for future work include
phage display to bind to the transcription factor Gal 80 (1) continued development of new PNA designs and new
can successfully recruit Gal 80 to a target site on DNA strategies for strand invasion; (2) continued develop-
[36]. More recently, PNA-peptide conjugates have also ment of improved methods for cellular delivery, with a
been shown to be able to activate gene expression in focus on optimal nuclear delivery; and (3) unambiguous
mammalian cell extract [74]. Such artificial transcription and thoroughly controlled demonstrations that PNAs
factors would be an elegant strategy for developing en- can recognize chromosomal DNA inside cells. Demon-
tirely synthetic agents for activating gene expression. strations may involve inhibition of gene expression, acti-
Similar strategies have also been reported using poly- vation of gene expression, or introduction of mutations;
amides [68] and TFOs [69]. (4) determination of the rules that govern successful
Challenges for future research will include the design strand invasion inside cells so that the wider community
or selection of efficient transcriptional activators that is convinced that PNAs can be useful tools; (5) optimiza-
will also be stable inside cells. When combined with tion of pharmacokinetics and biodistribution, and (6)
improved strategies for efficient strand invasion and effi- development of antigene PNAs for cell culture, animal
cient methods for cellular delivery, such synthetic PNA studies, and clinical development.
activator conjugates may prove to be powerful tools To achieve these goals it will be necessary to demon-
for increasing transcription. Since there are no general strate rules for the recognition of chromosomal DNA
methods for increasing gene expression in mammalian by PNAs. Such comprehensive studies will require a
cells, synthetic activators would be widely useful. significant number of oligomers, but we emphasize that
Introduction of Mutations it is not difficult to synthesize, solubilize, or work with
Correction of the mutations that cause genetic disease PNAs. Groups working with PNA should set high stan-
is a major unmet therapeutic need. Glazer and col- dards for themselves and be held to high standards by
leagues reported that upon introduction into cultured their colleagues. With systematically designed groups
mammalian cells, a PNA directed to the supFG1 gene of PNAs in hand, it should be possible to set up a design
was able to induce mutation frequencies at a frequency cycle to test hypotheses about susceptible sequences,
of 0.1% up to 10-fold higher than background [70]. Anal- obtain data, and then redesign the experiment strategy
ysis of the mutations produced by the PNA suggested to achieve improved results and facilitate in vivo applica-
that the bound PNA acts as a mutagenic lesion and may tion using these powerful molecular tools.
cause replication slippage errors. More recently, Glazer
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